BD Announces 2016 Analyst Day and Webcast

Nov 17, 2016

Franklin Lakes, NJ (November 14, 2016) - BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will host an institutional investor and analyst meeting on Thursday, November 17, 2016 in New York City from 8:30 a.m. - 3:30 p.m. (ET). The meeting will update the investment community on BD's plans to create long term value for its shareholders.

A live webcast of the event will be accessible through BD's website at A replay of the webcast will be available through Thursday, November 24, 2016.

About BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit

For more information on BD, please visit

Kristen Cardillo

201 847 5657

Monique N. Dolecki

201 847 5378

Back to News Releases